News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,382 Results
Type
Article (39322)
Company Profile (247)
Press Release (651813)
Section
Business (204002)
Career Advice (2002)
Deals (35400)
Drug Delivery (90)
Drug Development (80923)
Employer Resources (169)
FDA (16123)
Job Trends (14824)
News (344826)
Policy (32468)
Tag
Academia (2531)
Alliances (49300)
Alzheimer's disease (1302)
Approvals (16094)
Artificial intelligence (191)
Bankruptcy (355)
Best Places to Work (11634)
Biotechnology (175)
Breast cancer (216)
Cancer (1619)
Cardiovascular disease (123)
Career advice (1668)
Cell therapy (326)
Clinical research (65112)
Collaboration (624)
Compensation (339)
COVID-19 (2557)
C-suite (146)
Data (1526)
Diabetes (203)
Diagnostics (6248)
Earnings (85209)
Employer resources (146)
Events (110648)
Executive appointments (536)
FDA (16960)
Funding (566)
Gene therapy (227)
GLP-1 (639)
Government (4352)
Healthcare (18753)
Infectious disease (2661)
Inflammatory bowel disease (115)
Interviews (309)
IPO (16439)
Job creations (3628)
Job search strategy (1419)
Layoffs (432)
Legal (7879)
Lung cancer (243)
Manufacturing (226)
Medical device (13249)
Medtech (13254)
Mergers & acquisitions (19300)
Metabolic disorders (529)
Neuroscience (1691)
NextGen: Class of 2025 (6508)
Non-profit (4475)
Northern California (1962)
Obesity (301)
Opinion (190)
Parkinson's disease (114)
Patents (143)
People (56754)
Phase I (20273)
Phase II (28683)
Phase III (21358)
Pipeline (655)
Postmarket research (2562)
Preclinical (8565)
Radiopharmaceuticals (241)
Rare diseases (306)
Real estate (5894)
Regulatory (21847)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1704)
Startups (3567)
United States (17636)
Vaccines (601)
Weight loss (204)
Date
Last 7 days (614)
Last 30 days (2475)
Last 365 days (34570)
2025 (3262)
2024 (35217)
2023 (40076)
2022 (51175)
2021 (55710)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26347)
2012 (28571)
2011 (29266)
2010 (27328)
Location
Africa (715)
Arizona (208)
Asia (37450)
Australia (6122)
California (4505)
Canada (1636)
China (373)
Colorado (205)
Connecticut (214)
Europe (80262)
Florida (658)
Georgia (158)
Illinois (446)
Indiana (252)
Maryland (713)
Massachusetts (3470)
Michigan (194)
Minnesota (326)
New Jersey (1282)
New York (1292)
North Carolina (809)
Northern California (1962)
Ohio (164)
Pennsylvania (1055)
South America (1093)
Southern California (1704)
Texas (660)
Utah (137)
Washington State (450)
691,382 Results for "aerogen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.
Late in 2021, Aerogen® and CanSinoBIO announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia Air™ utilizing Aerogen’s proprietary aerosol drug delivery technology.
November 14, 2022
·
7 min read
Drug Development
Aerogen® and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery
Following months of collaborative development work, Aerogen® and CanSinoBIO have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia™ utilizing Aerogen’s proprietary vibrating mesh aerosol drug delivery technology.
December 9, 2021
·
5 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025
February 7, 2025
·
4 min read
Press Releases
Medera, Inc. to Participate in Two Upcoming Investor Conferences
February 7, 2025
·
12 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 3, 2025
·
1 min read
Business
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
Aerogen Pharma, and Nuance Pharma (“Nuance”), today announce an exclusive agreement to join forces in Greater China to develop a superior, non-invasive approach to treatment of RDS, a life-threatening condition of preterm infants associated with long-term lung health issues in survivors.
December 22, 2021
·
5 min read
1 of 69,139
Next
